David H. Huffman - Concepedia

Concepedia

Author

David H. Huffman

University of Kansas Medical Center

Also Known As

D H Huffman, D. H. HUFFMAN, D. H. Huffman, DAVID HUFFMAN, David H. Huffman, David Huffman

46

Publications

1.7K

Citations

23

H-Index

69

Concepts

All Affiliations

University of Kansas Medical Center The University of Kansas Health System United States Department of Veterans Affairs National Cancer Institute Cancer Research Center

DH

About

David H. Huffman is an author at University of Kansas Medical Center specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.5K
2	Health Sciences	3	3	151
3	Natural Sciences	1	1	14
4	Public Health	1	1	41
5	Anesthesia	1	1	78

David H. Huffman

×

32

Publications

1.7K

Citations

23

H-Index

	Year	Citations
Pharmacokinetics of methotrexate Daniel L. Azarnoff, Suk Han Wan, David H. Huffman Clinical Pharmacology & Therapeutics Chemoprevention StrategyPathologyPharmacotherapyMetronomic ChemotherapyPre-clinical Pharmacology	1974	156
Pharmacokinetics of drugs in patients with the nephrotic syndrome. R Gugler, Don W. Shoeman, David H. Huffman, Journal of Clinical Investigation GlomerulonephritisHypertensionRenal FunctionMedicineUnbound Diphenylhydantoin	1975	141
Pharmacokinetics of methotrexate David H. Huffman, Suk Han Wan, Daniel L. Azarnoff, Clinical Pharmacology & Therapeutics Therapeutic Drug MonitoringOncologySteady StatePharmacological StudyPlasma Disappearance	1973	131
Effect of route of administration and effusions on methotrexate pharmacokinetics. Suk Han Wan, David H. Huffman, Daniel L. Azarnoff, PubMed Therapeutic Drug MonitoringTranslational MedicineOncologyPharmacokinetic ModelingMg Mtx	1974	124
Absorption of orally given digoxin preparations. David H. Huffman, Daniel L. Azarnoff PubMed Therapeutic Drug MonitoringPharmacological StudyDigoxin PreparationsMedicinePhysiology	1972	96
Daunorubicin metabolism in acute nonlymphocytic leukemia David H. Huffman, Robert S. Benjamin, Nicholas R. Bachur Clinical Pharmacology & Therapeutics Mixed-phenotype Acute LeukemiaPharmacotherapyPharmacodynamic ModelingHematological MalignancyMolecular Pharmacology	1972	91
Impairment of antipyrine clearance in humans by propranolol. D J Greenblatt, Käte Franke, David H. Huffman Circulation Propranolol TreatmentMolecular PharmacologyThus PropranololPharmacological StudyMedicine	1978	78
Absorption of Orally Given Digoxin Preparations David H. Huffman JAMA Therapeutic Drug MonitoringPharmaceutical ScienceMedicinePhysiologyToxicology	1972	78
Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man David H. Huffman, Don W. Shoeman, Daniel L. Azarnoff Biochemical Pharmacology Plasma EliminationAdrenal GlandUrologyMedicineAdrenal Health	1974	71
The Effect of Spironolactone on Antipyrine Metabolism in Man David H. Huffman, Don W. Shoeman, Pertti J. Pentikäinen, Pharmacology Molecular PharmacologyAntipyrine MetabolismMedicinePhysiologyIncreased Excretion	1973	70

Page 1